Experiments on melanoma xenografts in mice showed that cancer cells with silenced SESN2 produced smaller tumours, which the authors attributed to increased survival of inoculant cells due to SESN2’s protection from ROS and possibly the activation of pro-survival AKT [31]. This evidence concerns the gene AKT1 and neoplasm.